Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H23F3N2O4S |
| Molecular Weight | 504.521 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1=C(CCC2=NOC3=CC(OCC(O)=O)=C(C)C=C23)SC(=N1)C4=CC=C(C=C4)C(F)(F)F
InChI
InChIKey=WWKYLBGQYALEDL-UHFFFAOYSA-N
InChI=1S/C25H23F3N2O4S/c1-13(2)23-21(35-24(29-23)15-4-6-16(7-5-15)25(26,27)28)9-8-18-17-10-14(3)19(33-12-22(31)32)11-20(17)34-30-18/h4-7,10-11,13H,8-9,12H2,1-3H3,(H,31,32)
Senju Pharmaceutical is developing fonadelpar (also known as SJP-0035), a peroxisome proliferator activated receptor delta agonist as an ophthalmic solution. Fonadelpar was studied in phase III clinical trial in the USA for the treatment of patients with dry eye disease. This study was successfully completed. In addition, fonadelpar was involved in phase II clinical trial in the USA for the treatment of patients with moderate to severe corneal epithelial disorders. Besides, Senju Pharmaceutical also plans a phase II trial for corneal disorders in Japan.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
BC-86
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
C170003
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL3545186
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
FK5ZAD810Z
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
515138-06-4
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
9827461
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
300000034227
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY | |||
|
10105
Created by
admin on Mon Mar 31 22:08:50 GMT 2025 , Edited by admin on Mon Mar 31 22:08:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
